Johns Hopkins ABX Guide
Cefepime/enmetazobactam
INDICATIONS
FDA
FDA
- Exblifep (cefepime/enmetazobactam) is indicated in patients 18 years and older for the treatment of complicated urinary tract infections (cUTI), including pyelonephritis.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Resistant Gram-negative infections, including ESBL-producing and certain carbapenemase-producing bacteria
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: December 19, 2025
Citation
Dzintars, Kathryn. "Cefepime/enmetazobactam." Johns Hopkins ABX Guide, The Johns Hopkins University, 2025. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540803/all/Cefepime_enmetazobactam.
Dzintars K. Cefepime/enmetazobactam. Johns Hopkins ABX Guide. The Johns Hopkins University; 2025. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540803/all/Cefepime_enmetazobactam. Accessed December 31, 2025.
Dzintars, K. (2025). Cefepime/enmetazobactam. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540803/all/Cefepime_enmetazobactam
Dzintars K. Cefepime/enmetazobactam [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2025. [cited 2025 December 31]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540803/all/Cefepime_enmetazobactam.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cefepime/enmetazobactam
ID - 540803
A1 - Dzintars,Kathryn,Pharm.D., BCPS
Y1 - 2025/12/19/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540803/all/Cefepime_enmetazobactam
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
